Shibutani M, Nagahara H, Fukuoka T, Iseki Y, et al. Combining Bevacizumab With Trifluridine/Thymidine Phosphorylase Inhibitor Improves the Survival Outcomes Regardless of the Usage History of Bevacizumab in Front-line Treatment of Patients With Metastatic Colorectal Cancer. Anticancer Res 2020;40:4157-4163.
PMID: 32620665